Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

AP/Press Association Images

A Dublin breast-implant maker has raised millions - including from the owners of Barry's Tea

GC Aesthetics aims to become the largest supplier of the product outside the US.

DUBLIN-BASED BREAST IMPLANT maker GC Aesthetics has raised $20 million in its latest funding round, which included backing from the owners of Barry’s Tea.

The company said the money, its Series D financing round, would be used to help it become the largest supplier of the cosmetic surgery product outside the US.

Mid-last year GC Aesthetics filed a prospectus to float on the Nasdaq stock exchange with plans to reportedly raise $75 million in the process.

However the idea was shelved in September, with the company citing a global downturn in share markets and instability in emerging economies as the reasons behind it abandoning the plans.

A large chunk of its sales come from Latin America, including Brazil – where a recession has continued to deepen this year.

GC Aesthetics instead opted to continue with private funding after raising $74 million, mostly in loans, during 2014 and another $10 million last year.

Barry’s Tea and Oyster

It said the latest backing included support from previous investors, which included Barry’s Tea Holdings – whose owner Tony Barry runs the famous tea business.

Other investors include Irish e-learning entrepreneur Bill McCabe’s Oyster Capital. McCabe also serves as a director at the breast-implant firm.

GC Aesthetics CEO Ayse Kocak said she was confident investors’ trust in the company “will be rewarded by our continued expansion and growth”.

The latest accounts for the company show its sales hit nearly $53 million in 2014, up 18% on the figure for the previous year. However pre-tax losses during the same period snowballed to $90 million, an increase on the $18.5 million loss posted in 2013.

The vast majority of its losses for the year came from finance expenses, which included $27.5 million paid in interest on investors’ preference shares from previous funding rounds.

GC Aesthetics has its head office in Sandyford and manufacturing facilities in both the UK and France, where it operates under the Nagor and Eurosilicone brands respectively. It employs around 400 people worldwide.

Written by Peter Bodkin and posted on Fora.ie

Read: The latest male must-have: the moustache implant >

Read: Trinity scientists discover how to attack a bacteria that causes cystic fibrosis infections >

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

View 19 comments
Close
19 Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.
    JournalTv
    News in 60 seconds